In Vitro Activity of Micafungin against Planktonic and Sessile Candida albicans Isolates

被引:22
作者
Jacobson, Melissa J. [2 ]
Steckelberg, Kathryn E. [2 ]
Piper, Kerryl E. [2 ]
Steckelberg, James M. [2 ]
Patel, Robin [1 ,2 ]
机构
[1] Mayo Clin, Coll Med, Div Clin Microbiol, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Med, Div Infect Dis, Rochester, MN 55905 USA
关键词
BIOFILM FORMATION; CASPOFUNGIN; SUSCEPTIBILITY; ANIDULAFUNGIN;
D O I
10.1128/AAC.01724-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Planktonic and sessile susceptibilities to micafungin were determined for 30 clinical isolates of Candida albicans obtained from blood or other sterile sites. Planktonic and sessile MIC(90)s for micafungin were 0.125 and 1.0 mu g/ml, respectively.
引用
收藏
页码:2638 / 2639
页数:2
相关论文
共 13 条
[1]  
[Anonymous], 2008, Approved standard M27-A. A National Committee for Clinical Laboratory Standards
[2]   In vitro activity of caspofungin against Candida albicans biofilms [J].
Bachmann, SP ;
VandeWalle, K ;
Ramage, G ;
Patterson, TF ;
Wickes, BL ;
Graybill, JR ;
López-Ribot, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3591-3596
[3]   In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth [J].
Cateau, Estelle ;
Rodier, Marie-Helene ;
Imbert, Christine .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) :153-155
[4]   Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance [J].
Chandra, J ;
Kuhn, DM ;
Mukherjee, PK ;
Hoyer, LL ;
McCormick, T ;
Ghannoum, MA .
JOURNAL OF BACTERIOLOGY, 2001, 183 (18) :5385-5394
[5]   Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals [J].
Choi, Hyun Woo ;
Shin, Jong Hee ;
Jung, Sook In ;
Park, Kyung Hwa ;
Cho, Duck ;
Kee, Seung Jung ;
Shin, Myung Geun ;
Suh, Soon Pal ;
Ryang, Dong Wook .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1520-1523
[6]   BIOFILM FORMATION BY CANDIDA SPECIES ON THE SURFACE OF CATHETER MATERIALS IN-VITRO [J].
HAWSER, SP ;
DOUGLAS, LJ .
INFECTION AND IMMUNITY, 1994, 62 (03) :915-921
[7]   In vitro activity of anidulafungin against Candida albicans biofilms [J].
Jacobson, Melissa J. ;
Piper, Kerryl E. ;
Nguyen, Gary ;
Steckelberg, James M. ;
Patel, Robin .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2242-2243
[8]   Antifungal susceptibility of Candida biofilms:: Unique efficacy of amphotericin B lipid formulations and echinocandins [J].
Kuhn, DM ;
George, T ;
Chandra, J ;
Mukherjee, PK ;
Ghannoum, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) :1773-1780
[9]   Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis [J].
Laverdière, M ;
Lalonde, RG ;
Baril, JG ;
Sheppard, DC ;
Park, S ;
Perlin, DS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :705-708
[10]  
Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001